Literature DB >> 4548552

Radioimmunoassay for methotrexate.

L Levine, E Powers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4548552

Source DB:  PubMed          Journal:  Res Commun Chem Pathol Pharmacol        ISSN： 0034-5164


× No keyword cloud information.
  5 in total

1.  A pharmacokinetic model for high-dose methotrexate infusions in man.

Authors:  S D Reich; N R Bachur; R H Goebel; M Berman
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

Review 2.  The practical benefits of pharmacokinetics in the use of antineoplastic agents.

Authors:  C Erlichman; R C Donehower; B A Chabner
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

3.  Competitive protein binding assay for methotrexate.

Authors:  C E Myers; M E Lippman; H M Elliot; B A Chabner
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

4.  Comparison of plasma and tissue levels of ZD1694 (Tomudex), a highly polyglutamatable quinazoline thymidylate synthase inhibitor, in preclinical models.

Authors:  G W Aherne; E Ward; N Lawrence; D Dobinson; S J Clarke; H Musgrove; F Sutcliffe; T Stephens; A L Jackman
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Development and application of a radioimmunoassay for methotrexate.

Authors:  G W Aherne; E M Piall; V Marks
Journal:  Br J Cancer       Date:  1977-11       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.